| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 10.51▲ | 10.51▲ | 10.52▲ | 9.80▲ | 9.49▲ |
| MA10 | 10.49▲ | 10.51▲ | 10.31▲ | 9.52▲ | 9.25▲ |
| MA20 | 10.50▲ | 10.24▲ | 9.90▲ | 9.37▲ | 13.33▼ |
| MA50 | 10.52▲ | 9.73▲ | 9.45▲ | 9.73▲ | 11.08▼ |
| MA100 | 10.34▲ | 9.44▲ | 9.38▲ | 13.31▼ | 16.02▼ |
| MA200 | 9.93▲ | 9.36▲ | 9.20▲ | 11.34▼ | 29.75▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | -0.013▼ | 0.062▲ | 0.251▲ | -0.623▼ |
| RSI | 53.085▲ | 67.035▲ | 72.969▲ | 59.519▲ | 46.559▼ |
| STOCH | 53.351 | 52.553 | 81.158▲ | 54.800 | 25.049 |
| WILL %R | -32.075 | -31.092 | -15.102▲ | -9.343▲ | -87.260▼ |
| CCI | 79.290 | 39.390 | 68.339 | 225.926▲ | -36.706 |
|
Wednesday, January 07, 2026 04:57 AM
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced that the company will present ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 08/01/26 | 10.72 | 10.72 | 10.34 | 10.535 | 5,774,947 |
| 07/01/26 | 9.84 | 10.58 | 9.77 | 10.13 | 5,085,858 |
| 06/01/26 | 9.37 | 10.17 | 9.31 | 9.73 | 4,307,364 |
| 05/01/26 | 9.21 | 9.70 | 9.13 | 9.37 | 5,783,651 |
| 02/01/26 | 9.23 | 9.36 | 9.05 | 9.21 | 2,736,215 |
| 31/12/25 | 9.06 | 9.135 | 8.94 | 8.99 | 3,020,988 |
| 30/12/25 | 9.17 | 9.25 | 8.99 | 9.06 | 2,191,326 |
| 29/12/25 | 9.34 | 9.36 | 8.9814 | 9.14 | 4,004,588 |
| 26/12/25 | 9.57 | 9.57 | 9.16 | 9.44 | 1,839,871 |
| 24/12/25 | 9.46 | 9.62 | 9.26 | 9.59 | 1,450,650 |
|
|
||||
|
|
||||
|
|